Outcomes of Allogeneic Hematopoietic Cell Transplantation in Patients with Myelofibrosis with Prior Exposure to Janus Kinase 1/2 Inhibitors
2015 · Biology of Blood and Marrow Transplantation · 142 citations
https://doi.org/10.1016/j.bbmt.2015.10.005
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
37
Papers
360
Citations
8
h-index
8
i10-index
Mohamed Shanavas is an academic researcher from University of Queensland. The author has contributed to research in topics: Lymphoma Diagnosis and Treatment & Acute Myeloid Leukemia Research & Cancer Immunotherapy and Biomarkers. The author has an h-index of 8, co-authored 32 publications.
ORCID: 0000-0001-6558-1721https://doi.org/10.1016/j.bbmt.2015.10.005
https://doi.org/10.1016/j.ebiom.2024.105468
Click to start Chat